Negative regulation of immunoreceptor signaling

Annual Review of Immunology

Volumn 20, Issue , 2002, Pages 669-707

  Veillette, André ^a   Latour, Sylvain ^a   Davidson, Dominique ^a  

^a CLIN RESEARCH INSTITUTE OF MONTREAL   (Canada)

Author keywords

Adaptor; Csk; Inhibition; ITIM; Phosphatase

Indexed keywords

ADAPTOR PROTEIN; CD148 ANTIGEN; CD45 ANTIGEN; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; LIGASE; LIPID PHOSPHATASE; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PROTEIN CSK; PROTEIN KINASE; PROTEIN SHC; PROTEIN SHIP 1; PROTEIN TYROSINE KINASE; PROTEIN TYROSINE PHOSPHATASE; RAS PROTEIN; UBIQUITIN; UNCLASSIFIED DRUG;

CELL ACTIVATION; ENZYME CONFORMATION; IMMUNE RESPONSE; IMMUNOCOMPETENT CELL; LIGAND BINDING; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE; REGULATORY MECHANISM; REVIEW; SIGNAL TRANSDUCTION; T LYMPHOCYTE ACTIVATION;

ANIMALS; B-LYMPHOCYTES; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MODELS, IMMUNOLOGICAL; PROTEIN-TYROSINE KINASES; PROTEIN-TYROSINE-PHOSPHATASE; RECEPTORS, IMMUNOLOGIC; SHP1 PROTEIN TYROSINE PHOSPHATASE; SIGNAL TRANSDUCTION; SRC-FAMILY KINASES; T-LYMPHOCYTES;

EID: 0036219193     PISSN: 07320582     EISSN: None     Source Type: Book Series    
DOI: 10.1146/annurev.immunol.20.081501.130710     Document Type: Review

References (181)

1. Signal transduction by lymphocyte antigen receptors
2. Antigen receptor signaling: Integration of protein tyrosine kinase functions
3. The role of protein tyrosine kinases and protein tyrosine phosphatases in T cell antigen receptor signal transduction
4. Signal transduction by the TCR for antigen
5. Signalling through the high-affinity IgE receptor Fc epsilonRI
6. Fc receptor biology
7. Activating receptors and coreceptors involved in human natural killer cell-mediated cytolysis
8. A family of inhibitory and activating Ig-like receptors that modulate function of lymphoid and myeloid cells
9. Functional dissection of BCR signaling pathways
10. Proximal protein tyrosine kinases in immunoreceptor signaling
11. The Src and Csk families of tyrosine protein kinases in hemopoietic cells
12. Positive and negative regulation of Src-family membrane kinases by CD45
13. CD45 and Src-family kinases: And now for something completely different
14. The Syk/ZAP-70 protein tyrosine kinase connection to antigen receptor signalling processes
15. Tec kinases: A family with multiple roles in immunity
16. Tec kinases: Modulators of lymphocyte signaling and development
17. Adaptors and molecular scaffolds in immune cell signaling
18. Adapter proteins in lymphocyte antigen-receptor signaling
19. Adapters in lymphocyte signalling
20. Cloning of a complementary DNA for a protein-tyrosine kinase that specifically phosphorylates a negative regulatory site of p60c-src
21. Constitutive activation of Src family kinases in mouse embryos that lack Csk
22. Disruption of the csk gene, encoding a negative regulator of Src family tyrosine kinases, leads to neural tube defects and embryonic lethality in mice
23. Negative regulation of T-cell receptor signalling by tyrosine protein kinase p50csk
24. Differential involvement of Src family kinases in Fc gamma receptor-mediated phagocytosis
25. Roles of C-terminal Src kinase in the initiation and the termination of the high affinity IgE receptor-mediated signaling
26. Functional analysis of Csk in signal transduction through the B-cell antigen receptor
27. Csk controls antigen receptor-mediated development and selection of T-lineage cells
28. Autonomous maturation of alpha/beta T lineage cells in the absence of COOH-terminal Src kinase (Csk)
29. Requirement of the SH3 and SH2 domains for the inhibitory function of tyrosine protein kinase p50csk in T lymphocytes
30. Association of inhibitory tyrosine protein kinase p50csk with protein tyrosine phosphatase PEP in T cells and other hemopoietic cells
31. Inhibitory tyrosine protein kinase p50csk is associated with protein-tyrosine phosphatase PTP-PEST in hemopoietic and non-hemopoietic cells
32. Detection of a physical and functional interaction between Csk and Lck which involves the SH2 domain of Csk and is mediated by autophosphorylation of Lck on tyrosine 394
33. The SH2 domain is required for stable phosphorylation of p56lck at tyrosine 505, the negative regulatory site
34. Transmembrane phosphoprotein Cbp regulates the activities of Src-family tyrosine kinases
35. Phosphoprotein associated with glycosphingolipid-enriched microdomains (PAG), a novel ubiquitously expressed transmembrane adaptor protein, binds the protein tyrosine kinase csk and is involved in regulation of T cell activation
36. Transmembrane phosphoprotein Cbp positively regulates the activity of the carboxyl-terminal Src kinase
37. Release from tonic inhibition of T cell activation through transient displacement of C-terminal Src kinase (Csk) from lipid rafts
38. The nonreceptor protein-tyrosine kinase CSK complexes directly with the GTPase-activating protein-associated p62 protein in cells expressing v-Src or activated c-Src
39. Dok-3, a novel adapter molecule involved in the negative regulation of immunoreceptor signaling
40. Structural and functional dissection of the cytoplasmic domain of the transmembrane adaptor protein SIT (SHP2-interacting transmembrane adaptor protein)
41. SHP2-interacting transmembrane adaptor protein (SIT), a novel disulfide-linked dimer regulating human T cell activation
42. Analysis of the binding of the Src homology 2 domain of Csk to tyrosine-phosphorylated proteins in the suppression and mitotic activation of c-Src
43. A novel protein tyrosine phosphatase expressed in lin(lo)CD34(hi)Sca(hi) hematopoietic progenitor cells
44. SH2 domain-mediated interaction of inhibitory protein tyrosine kinase Csk with protein tyrosine phosphatase-HSCF
45. Activation of the COOH-terminal Src kinase (Csk) by cAMP-dependent protein kinase inhibits signaling through the T cell receptor
46. Identification of csk tyrosine phosphorylation sites and a tyrosine residue important for kinase domain structure
47. Chk, a Csk family tyrosine protein kinase, exhibits Csk-like activity in fibroblasts, but not in an antigen-specific T-cell line
48. Genetic analysis of protein tyrosine phosphatases
49. From form to function: Signaling by protein tyrosine phosphatases
50. Roles of the SHP-1 tyrosine phosphatase in the negative regulation of cell signalling
51. Cytoplasmic protein tyrosine phosphatases SHP-1 and SHP-2: Regulators of B cell signal transduction
52. Shp-2 tyrosine phosphatase: Signaling one cell or many
53. Immune signalling: SHP-2 docks at multiple ports
54. SHP-2, SH2-containing protein tyrosine phosphatase-2
55. Differential functions of the two Src homology 2 domains in protein tyrosine phosphatase SH-PTP1
56. Intramolecular regulation of protein tyrosine phosphatase SH-PTP1: A new function for Src homology 2 domains
57. Inhibition of the activity of protein tyrosine phosphate 1C by its SH2 domains
58. Crystal structure of the tyrosine phosphatase SHP-2
59. Motheaten and viable motheaten mice have mutations in the haematopoietic cell phosphatase gene
60. Mutations at the murine motheaten locus are within the hematopoietic cell protein-tyrosine phosphatase (Hcph) gene
61. Expression and catalytic activity of the tyrosine phosphatase PTP1C is severely impaired in motheaten and viable motheaten mice
62. Lack of SHPTP1 results in src-family kinase hyperactivation and thymocyte hyperresponsiveness
63. Signaling capacity of the T cell antigen receptor is negatively regulated by the PTP1C tyrosine phosphatase
64. Involvement of the SHP-1 tyrosine phosphatasein regulation of T cell selection
65. Cutting edge: The tyrosine phosphatase SHP-1 regulates thymocyte positive selection
66. TCR signaling thresholds regulating T cell development and activation are dependent upon SHP-1
67. Direct regulation of ZAP-70 by SHP-1 in T cell antigen receptor signaling
68. Surface expression of hemopoietic cell phosphatase fails to complement CD45 deficiency and inhibits TCR-mediated signal transduction in a Jurkat T cell clone
69. Involvement of SHP-1 tyrosine phosphatase in TCR-mediated signaling pathways in lipid rafts
70. Targeting Src homology 2 domain-containing tyrosine phosphatase (SHP-1) into lipid rafts inhibits CD3-induced T cell activation
71. Identification of the tyrosine phosphatase PTP1C as a B cell antigen receptor-associated protein involved in the regulation of B cell signaling
72. Protein-tyrosine phosphatase SHP-1 is dispensable for FcgammaRIIB-mediated inhibition of B cell antigen receptor activation
73. Protein tyrosine phosphatase 1C negatively regulates antigen receptor signaling in B lymphocytes and determines thresholds for negative selection
74. Expression of dominant-negative src-homology domain 2-containing protein tyrosine phosphatase-1 results in increased Syk tyrosine kinase activity and B cell activation
75. Immunoreceptor tyrosine-based inhibition motifs
76. Inhibitory pathways triggered by ITIM-containing receptors
77. Inhibitory receptors abound?
78. Immune inhibitory receptors
79. NK cell receptors
80. Signaling pathways engaged by NK cell receptors: Double concerto for activating receptors, inhibitory receptors and NK cells
81. gp49B1-alpha(v)beta3 interaction inhibits antigen-induced mast cell activation
82. Increased severity of local and systemic anaphylactic reactions in gp49B 1-deficient mice
83. Characterization of hematopoietic intracellular protein tyrosine phosphatases: Description of a phosphatase containing an SH2 domain and another enriched in proline-, glutamic acid-, serine-, and threonine-rich sequences
84. Cloning and characterization of a lymphoid-specific, inducible human protein tyrosine phosphatase, Lyp
85. Nuclear localization of the PEP protein tyrosine phosphatase
86. Sequence requirements for association of protein-tyrosine phosphatase PEP with the Src homology 3 domain of inhibitory tyrosine protein kinase p50(csk)
87. Cooperative inhibition of T-cell antigen receptor signaling by a complex between a kinase and a phosphatase
88. Characterization of TCR-induced receptor-proximal signaling events negatively regulated by the protein tyrosine phosphatase PEP
89. Requirement of PEST domain tyrosine phosphatase PEP in B cell antigen receptor-induced growth arrest and apoptosis
90. Cloning and expression of PTP-PEST. A novel, human, nontransmembrane protein tyrosine phosphatase
91. Murine protein tyrosine phosphatase-PEST, a stable cytosolic protein tyrosine phosphatase
92. PTP-PEST, a scaffold protein tyrosine phosphatase, negatively regulates lymphocyte activation by targeting a unique set of substrates
93. Hic-5, a paxillin homologue, binds to the protein-tyrosine phosphatase PEST (PTP-PEST) through its LIM 3 domain
94. Combination of gene targeting and substrate trapping to identify substrates of protein tyrosine phosphatases using PTP-PEST as a model
95. Direct association of protein-tyrosine phosphatase PTP-PEST with paxillin
96. Association of PTP-PEST with the SH3 domain of p130cas; a novel mechanism of protein tyrosine phosphatase substrate recognition
97. Identification of p130(cas) as a substrate for the cytosolic protein tyrosine phosphatase PTP-PEST
98. Phosphotyrosine-independent binding of SHC to the NPLH sequence of murine protein-tyrosine phosphatase-PEST. Evidence for extended phosphotyrosine binding/phosphotyrosine interaction domain recognition specificity
99. Protein tyrosine phosphatase-PEST regulates focal adhesion disassembly, migration, and cytokinesis in fibroblasts
100. Regulation of fibroblast motility by the protein tyrosine phosphatase PTP-PEST
101. The CD45 tyrosine phosphatase: A positive and negative regulator of immune cell function
102. CD45: New jobs for an old acquaintance
103. Dimerization-induced inhibition of receptor protein tyrosine phosphatase function through an inhibitory wedge
104. Ligand-mediated negative regulation of a chimeric transmembrane receptor tyrosine phosphatase
105. CD148, a membrane protein tyrosine phosphatase, is able to induce tyrosine phosphorylation on human lymphocytes
106. Protein tyrosine phosphatase CD148-mediated inhibition of T-cell receptor signal transduction is associated with reduced LAT and phospholipase Cgammal phosphorylation
107. Negative regulation of human T cell activation by the receptor-type protein tyrosine phosphatase CD148
108. Cytoskeletal protein tyrosine phosphatase PTPH1 reduces T cell antigen receptor signaling
109. Inhibition of T cell signaling by mitogen-activated protein kinase-targeted hematopoietic tyrosine phosphatase (HePTP)
110. Negative regulation of T cell antigen receptor signal transduction by hematopoietic tyrosine phosphatase (HePTP)
111. Control of MAP kinase activation by the mitogen-induced threonine/tyrosine phosphatase PAC1
112. Lipid phosphatases in the immune system
113. Structure, function, and biology of SHIP proteins
114. The 145-kDa protein induced to associate with Shc by multiple cytokines is an inositol tetraphosphate and phosphatidylinositol 3, 4, 5-triphosphate 5-phosphatase
115. p150Ship, a signal transduction molecule with inositol polyphosphate5-phosphatase activity
116. Targeted disruption of SHIP leads to hemopoietic perturbations, lung pathology, and a shortened life span
117. The inositol polyphosphate 5-phosphatase ship is a crucial negative regulator of B cell antigen receptor signaling
118. Differential regulation of B cell development, activation, and death by the src homology 2 domain-containing 5′ inositol phosphatase (SHIP)
119. A dual role for Src homology 2 domain-containing inositol-5-phosphatase (SHIP) in immunity: Aberrant development and enhanced function of b lymphocytes in ship -/- mice
120. Altered responsiveness to chemokines due to targeted disruption of SHIP
121. The inositol phosphatase SHIP inhibits Akt/PKB activation in B cells
122. Targeted disruption of SHIP leads to Steel factor-induced degranulation of mast cells
123. The src homology 2-containing inositol phosphatase (SHIP) is the gatekeeper of mast cell degranulation
124. Role of the inositol phosphatase SHIP in B cell receptor-induced Ca2+ oscillatory response
125. Inhibitory modulation of B cell receptor-mediated Ca2+ mobilization by Src homology 2 domain-containing inositol 5′-phosphatase (SHIP)
126. SHIP is a negative regulator of growth factor receptor-mediated PKB/Akt activation and myeloid cell survival
127. A regulatory role for Src homology 2 domain-containing inositol 5′-phosphatase (SHIP) in phagocytosis mediated by Fc gamma receptors and complement receptor 3 (alpha(M)beta(2); CD11b/CD 18)
128. Regulation of SLAM-mediated signal transduction by SAP, the X-linked lymphoproliferative gene product
129. CDw150 associates with src-homology 2-containing inositol phosphatase and modulates CD95-mediated apoptosis
130. Novel p62dok family members, dok-4 and dok-5, are substrates of the c-Ret receptor tyrosine kinase and mediate neuronal differentiation
131. p56(dok-2) as a cytokine-inducible inhibitor of cell proliferation and signal transduction
132. The RasGAP-binding protein p62dok is a mediator of inhibitory FcgammaRIIB signals in B cells
133. SHP-1 regulation of p62(DOK) tyrosine phosphorylation in macrophages
134. Characterization of a novel member of the DOK family that binds and modulates Abl signaling
135. The Tek/Tie2 receptor signals through a novel Dok-related docking protein, Dok-R
136. FRIP, a hematopoietic cell-specific rasGAP-interacting protein phosphorylated in response to cytokine stimulation
137. Role of the rasGAP-associated docking protein p62(dok) in negative regulation of B cell receptor-mediated signaling
138. Recruitment of dok-R to the EGF receptor through its PTB domain is required for attenuation of erk MAP kinase activation
139. p62(dok), a negative regulator of Ras and mitogen-activated protein kinase (MAPK) activity, opposes leukemogenesis by p210(bcr-abl)
140. Mediation by the protein-tyrosine kinase Tec of signaling between the B cell antigen receptor and Dok-1
141. A novel transforming protein (SHC) with an SH2 domain is implicated in mitogenic signal transduction
142. Tyrosine phosphorylation of shc in response to B cell antigen receptor engagement depends on the SHIP inositol phosphatase
143. The adaptor protein shc is involved in the negative regulation of NK cell-mediated cytotoxicity
144. Identification of a second SH2-domain-containing protein closely related to the phosphatidylinositol polyphosphate 5-phosphatase SHIP
145. Partially distinct molecular mechanisms mediate inhibitory FcgammaRIIB signaling in resting and activated B cells
146. The lipid phosphatase SHIP2 controls insulin sensitivity
147. PTEN: Life as a tumor suppressor
148. The multiple roles of PTEN in tumor suppression
149. The PTEN tumor suppressor protein: An antagonist of phosphoinositide 3-kinase signaling
150. High cancer susceptibility and embryonic lethality associated with mutation of the PTEN tumor suppressor gene in mice
151. T cell-specific loss of Pten leads to defects in central and peripheral tolerance
152. The tumor suppressor PTEN regulates T cell survival and antigen receptor signaling by acting as a phosphatidylinositol 3-phosphatase
153. Deficiency of PTEN in Jurkat T cells causes constitutive localization of Itk to the plasma membrane and hyperresponsiveness to CD3 stimulation
154. Characterization of the B lymphocyte populations in Lyn-deficient mice and the role of Lyn in signal initiation and down-regulation
155. Impaired proliferation of peripheral B cells and indication of autoimmune disease in lyn-deficient mice
156. Multiple defects in the immune system of Lyn-deficient mice, culminating in autoimmune disease
157. Defective negative regulation of antigen receptor signaling in Lyn-deficient B lymphocytes
158. A double-edged kinase Lyn: A positive and negative regulator for antigen receptor-mediated signals
159. Inhibition of the B cell by CD22: A requirement for Lyn
160. Negative regulation of phagocytosis in murine macrophages by the Src kinase family member, Fgr
161. Cbl: Many adaptations to regulate protein tyrosine kinases
162. Lymphocyte signaling: Cb1 sets the threshold for autoimmunity
163. The Cbl protooncoprotein: A negative regulator of immune receptor signal transduction
164. The c-cbl proto-oncogene is preferentially expressed in thymus and testis tissue and encodes a nuclear protein
165. v-cbl, an oncogene from a dual-recombinant murine retrovirus that induces early B-lineage lymphomas
166. A rearrangement of the c-cbl proto-oncogene in HUT78 T-lymphoma cells results in a truncated protein
167. The sequences of the human and mouse c-cbl proto-oncogenes show v-cbl was generated by a large truncation encompassing a proline-rich domain and a leucine zipper-like motif
168. Cbl-mediated negative regulation of the Syk tyrosine kinase. A critical role for Cbl phosphotyrosine-binding domain binding to Syk phosphotyrosine 323
169. The linker phosphorylation site Tyr292 mediates the negative regulatory effect of Cbl on ZAP-70 in T cells
170. Inhibition of signaling through the B cell antigen receptor by the protooncogene product, c-Cbl, requires Syk tyrosine 317 and the c-Cbl phosphotyrosine-binding domain
171. The RING finger domain of Cbl is essential for negative regulation of the Syk tyrosine kinase
172. The Cbl proto-oncogene product negatively regulates the Src-family tyrosine kinase Fyn by enhancing its degradation
173. Perturbed regulation of ZAP-70 and sustained tyrosine phosphorylation of LAT and SLP-76 in c-Cbl-deficient thymocytes
174. Altered thymic positive selection and intracellular signals in Cbl-deficient mice
175. Tissue hyperplasia and enhanced T-cell signalling via ZAP-70 in c-Cbl-deficient mice
176. Cbl promotes ubiquitination of the T cell receptor zeta through an adaptor function of Zap-70
177. Cbl suppresses B cell receptor-mediated phospholipase C (PLC)-gamma2 activation by regulating B cell linker protein-PLC-gamma2 binding
178. Cbl-b regulates the CD28 dependence of T-cell activation
179. Negative regulation of lymphocyte activation and autoimmunity by the molecular adaptor Cbl-b
180. Cbl-b is a negative regulator of receptor clustering and raft aggregation in T cells
181. Cbl-b, a RING-type E3 ubiquitin ligase, targets phosphatidylinositol 3-kinase for ubiquitination in T cells